Siemens Healthineers Releases Test Kit for Coronavirus COVID-19

Siemens HealthineersSiemens Healthineers announced the availability of its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease. Test kits are already being shipped within the European Union for research use only (RUO) to expedite availability while the company continues to pursue Emergency Use Assessment and Listing (EUAL) from the World Health Organization (WHO) for clinical use. In addition, Siemens Healthineers has begun discussions with the U.S. Food and Drug Administration (FDA) for release of the test under Emergency Use Authorization (EUA). Both applications are in progress. While the controlled roll-out of the assay for research use is continuing, Siemens Healthineers is simultaneously expanding its production capacity.

"With this molecular diagnostic assay, we want to make a contribution to fight the current COVID-19 global pandemic by delivering fast and accurate SARS-CoV-2 testing," said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. "The Siemens Healthineers assay is designed to help researchers positively identify the virus in less than three hours so that healthcare professionals can proceed as quickly as possible with the necessary next steps on their patients’ triage paths."

Many molecular assays detect the presence of viral ribonucleic acid (RNA), determining the presence of the targeted virus directly in the patient sample. In this way, molecular testing is effective early in the lifecycle of the virus and is thus efficient in urgent testing situations, such as global pandemics. After regulatory approval, the commercial roll-out of the assay is intended in the U.S. and Europe.

The FTD SARS-CoV-2 Assay has been optimized on the Biomerieux EasyMag Extraction System and the Applied Biosystems 7500 Real-time PCR Thermocycler* and utilizes the same workflow, including PCR profile, as other FTD Respiratory Disease kits from Siemens Healthineers. It can be run in laboratories simultaneously with FTD Respiratory Pathogens 21**, a molecular syndromic testing panel from Siemens Healthineers that identifies 21 different upper respiratory pathogens that can cause acute respiratory infections.

The FTD SARS-CoV-2 Assay was developed by Fast Track Diagnostics, a Siemens Healthineers Company, in Esch-sur-Alzette, Luxembourg. Fast Track Diagnostics was acquired by Siemens Healthineers at the end of 2017.

* For research use
** CE-IVD labelled for diagnostic use in the EU. Product availability varies by country and is subject to local regulatory requirements.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion.

Most Popular Now

Philips Introduces ClarifEye Augmented R…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced ClarifEye Augmented Reality Surgical Navigation, an industry-first solution to advance minimally-invasive spine procedures in the Hybrid...

Artificial Intelligence in the Real Worl…

Royal Bolton NHS Foundation Trust has been much praised for its deployment of AI in the fight against Covid-19. Rizwan Malik, divisional medical director of the trust and managing director...

Senior Nurse adds to Clinical Expertise …

A senior nurse with more than 20 years' experience in the NHS has joined smart health tech provider Alcidion in a core role as a clinical consultant primarily working with...

Wearable Devices can Detect COVID-19 Sym…

Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, Mount Sinai researchers report in one of the first...

EU4Health: MEPs Reach Deal with Council …

The new EU health programme, worth 5.1 billion EUR, will help to fix shortcomings exposed by COVID-19 and boost quality and resilience of EU health systems. Parliament negotiators agreed on a...

Philips completes the acquisition of Bio…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote...

Computational Medicine - Moving from Unc…

Individual choices in medicine carry a certain amount of uncertainty. An innovative partnership at The University of Texas at Austin takes aim at medicine down to the individual level by applying...

Bury, Oldham, Rochdale and Trafford Go L…

Nearly half a million children's health records across Bury, Oldham, Rochdale and Trafford have been successfully integrated onto a new child health information system to support services in each area. The...

A Machine-Learning Approach to Finding T…

When the COVID-19 pandemic struck in early 2020, doctors and researchers rushed to find effective treatments. There was little time to spare. "Making new drugs takes forever," says Caroline Uhler...

Cybersecurity in Healthcare: HubIT Final…

17 February 2021, Online. The online international workshop "Cybersecurity within Healthcare Systems" takes place on the 17 of February 2021 from 10-13 am CET. The aim of this workshop is to...

Researchers Develop Data Tool that may I…

With the aid of sophisticated machine learning, researchers at UPMC and the University of Pittsburgh School of Medicine demonstrated that a tool they developed can rapidly predict mortality for patients...